High expression of pdl-1 in patients with triple negative breast cancer with residual tumor burden after neoadjuvant chemotherapy.

被引：1
|
作者：
Oner, Gizem [1 ]
Onder, Semen [1 ]
Karatay, Huseyin [1 ]
Tukenmez, Mustafa [1 ]
Muslumanoglu, Mahmut [1 ]
Igci, Abdullah [1 ]
Dinccag, Ahmet [1 ]
Ozmen, Vahit [1 ]
Aydiner, Adnan [1 ]
Yavuz, Ekrem [1 ]
Cabioglu, Neslihan [1 ]
机构：
[1] Istanbul Univ, Istanbul, Turkey
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 15期
关键词：
D O I：
10.1200/JCO.2018.36.15_suppl.e24136
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e24136
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Prognostic value of tumor-infiltrating lymphocyte subtypes in residual tumors of patients with triple-negative breast cancer after neoadjuvant chemotherapy
    Bai Yu-Ge
    Gao Guo-Xuan
    Zhang Hong
    Zhang Shuang
    Liu Yin-Hua
    Duan Xue-Ning
    Xu Ling
    中华医学杂志英文版, 2020, 133 (05) : 552 - 560
  • [32] Triple-negative breast cancer tumors in Peruvian patients: Worst prognostic to reach surgery after standard neoadjuvant chemotherapy.
    Vidaurre, T.
    Quintana Truyenque, S. M.
    Mantilla, R.
    Leon, M.
    Doimi, F.
    Vigil, C. E.
    Alegria, E. C.
    Mas, L.
    Suazo, F.
    Gomez, H. L.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [33] Prognostic Implications of the Residual Tumor Microenvironment after Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer Patients without Pathological Complete Response
    Lejeune, Marylene
    Reverte, Laia
    Sauras, Esther
    Gallardo, Noelia
    Bosch, Ramon
    Roso, Albert
    Petit, Anna
    Peg, Vicente
    Riu, Francisco
    Garcia-Fontgivell, Joan
    Ibanez, Jose
    Relea, Fernanda
    Vieites, Begona
    Bor, Catherine
    de la Cruz-Merino, Luis
    Arenas, Meritxell
    Rodriguez, Valerie
    Galera, Juana
    Korzynska, Anna
    Belhomme, Philippe
    Plancoulaine, Benoit
    alvaro, Tomas
    Lopez, Carlos
    CANCERS, 2023, 15 (03)
  • [34] Prognostic value of tumor-infiltrating lymphocyte subtypes in residual tumors of patients with triple-negative breast cancer after neoadjuvant chemotherapy
    Bai, Yu-Ge
    Gao, Guo-Xuan
    Zhang, Hong
    Zhang, Shuang
    Liu, Yin-Hua
    Duan, Xue-Ning
    Xu, Ling
    CHINESE MEDICAL JOURNAL, 2020, 133 (05) : 552 - 560
  • [35] Spatial transcriptomic analysis of tumor microenvironment in patients with triple negative breast cancer with residual disease after neoadjuvant chemotherapy with immune checkpoint inhibitor
    Kim, Ji-Yeon
    Park, Kyunghee
    Choi, Yoon La
    Lee, Jeong Eon
    Chae, Byung Joo
    Yu, Jonghan
    Kim, Seok Won
    Nam, Seok Jin
    Ahn, Jin Seok
    Park, Woong-Yang
    Park, Yeon Hee
    CANCER RESEARCH, 2024, 84 (06)
  • [36] Expression of Cyclin D1 protein in residual tumor after neoadjuvant chemotherapy for breast cancer
    S. L. Villegas
    S. Darb-Esfahani
    G. von Minckwitz
    J. Huober
    K. Weber
    F. Marmé
    J. Furlanetto
    C. Schem
    B. M. Pfitzner
    B. Lederer
    K. Engels
    S. Kümmel
    V. Müller
    K. Mehta
    C. Denkert
    S. Loibl
    Breast Cancer Research and Treatment, 2018, 168 : 179 - 187
  • [37] Expression of Cyclin D1 protein in residual tumor after neoadjuvant chemotherapy for breast cancer
    Villegas, S. L.
    Darb-Esfahani, S.
    von Minckwitz, G.
    Huober, J.
    Weber, K.
    Marme, F.
    Furlanetto, J.
    Schem, C.
    Pfitzner, B. M.
    Lederer, B.
    Engels, K.
    Kuemmel, S.
    Mueller, V.
    Mehta, K.
    Denkert, C.
    Loibl, S.
    BREAST CANCER RESEARCH AND TREATMENT, 2018, 168 (01) : 179 - 187
  • [38] Prognostic Influence of Residual Tumor-Infiltrating Lymphocyte Subtype After Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer
    da Silva, Jesse Lopes
    de Albuquerque, Lucas Zanetti
    Rodrigues, Fabiana Resende
    de Mesquita, Guilherme Gomes
    Fernandes, Priscila Valverde
    Thuler, Luiz Claudio Santos
    de Melo, Andreia Cristina
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [39] Comparative analysis of mutational patterns in triple negative breast cancer before and after neoadjuvant chemotherapy in patients with residual disease
    Singh, Ashish
    Georgy, Josh Thomas
    Dhananjayan, Sakthi
    Sigamani, Elanthenral
    John, Ajoy Oommen
    Joel, Anjana
    Chandramohan, Jagan
    Abarna, Rajadurai
    Rebekah, Grace
    Backianathan, Selvamani
    Abraham, Deepak Thomas
    Paul, Mazhuvanchary Jacob
    Chacko, Raju Titus
    Manipadam, Marie Therese
    Pai, Rekha
    GENE, 2024, 895
  • [40] An immunological signature to predict outcome in patients with triple-negative breast cancer with residual disease after neoadjuvant chemotherapy
    Blaye, C.
    Darbo, E.
    Debled, M.
    Brouste, V
    Velasco, V.
    Pinard, C.
    Larmonier, N.
    Pellegrin, I
    Tarricone, A.
    Arnedos, M.
    Commeny, J.
    Bonnefoi, H.
    Larmonier, C.
    MacGrogan, G.
    ESMO OPEN, 2022, 7 (04)
12345